Related references
Note: Only part of the references are listed.Podocytes as Target of Vitamin D
Yan C. Li
CURRENT DIABETES REVIEWS (2011)
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes
Dilip K. Deb et al.
KIDNEY INTERNATIONAL (2010)
Renoprotective effects of vitamin D analogs
Yan Chun Li
KIDNEY INTERNATIONAL (2010)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw et al.
LANCET (2010)
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT(1) receptor antagonist
Yan Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-κB pathway
Dilip K. Deb et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial
Pooneh Alborzi et al.
HYPERTENSION (2008)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Z. Zhang et al.
KIDNEY INTERNATIONAL (2008)
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
Zhongyi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter
Weihua Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo
Mark B. Meyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
Ian H. de Boer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin
Yosuke Takano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
A. Levin et al.
KIDNEY INTERNATIONAL (2007)
Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy
Y. Wang et al.
KIDNEY INTERNATIONAL (2006)
Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes
K. Yamauchi et al.
KIDNEY INTERNATIONAL (2006)
Mechanisms of disease: Hereditary proteinuria syndromes and mechanisms of proteinuria
K Tryggvason et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Vitamin D: More than a Bone-a-Fide hormone
ALM Sutton et al.
MOLECULAR ENDOCRINOLOGY (2003)
A new method for large scale isolation of kidney glomeruli from mice
M Takemoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D3-induced growth inhibition.
XM Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death
H Putaala et al.
HUMAN MOLECULAR GENETICS (2001)
Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements
M Quack et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
